Activation of mitogen-activated protein kinases in the non-ischemic myocardium of an acute myocardial infarction in rats.

As one of the signal transduction pathways related to myocardial remodeling, mitogen-activated protein kinases (MAPKs) possibly play an important role in ischemic heart disease, but it is still unknown whether myocardial MAPKs are activated in the non-ischemic region of an acute myocardial infarction (AMI). Therefore, the present study investigated the myocardial activity of extracellular signal-regulated kinases (ERKs), c-Jun NH2 terminal kinases (JNKs) and p38MAPK during the acute phase of an infarction of the rat heart, and measured the geometrical ventricular changes by echocardiography. All MAPKs were significantly activated in the ischemic myocardium (IM), non-ischemic septal wall (SW), and right ventricular wall (RV). Furthermore, the activation patterns of MAPKs differed in each region. The activation of p44ERK, JNKs and p38MAPK in the IM occurred rapidly after myocardial ischemia, followed by those in the SW and RV. The activator protein-1 DNA binding activities of the IM, SW and RV increased significantly at I day after coronary ligation. Echocardiography showed increased SW motion and RV dilatation. In conclusion, this is the first in vivo evidence that myocardial MAPKs are activated in the non-ischemic region of an AMI. Echocardiographic results suggest that acceleration of workload and/or stretch may partially induce the activation of MAPKs.

[1]  F Fedele,et al.  Harmonic imaging with Levovist for transthoracic echocardiographic reconstruction of left ventricle in patients with post-ischemic left ventricular dysfunction and suboptimal acoustic windows. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  Shokei Kim,et al.  Increased JNK, AP-1 and NF-κB DNA Binding Activities in Isoproterenol-induced Cardiac Remodeling , 1999 .

[3]  L. Bolognese,et al.  Early predictors of left ventricular remodeling after acute myocardial infarction. , 1999, American heart journal.

[4]  T. Yue,et al.  Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. , 1999, Circulation.

[5]  P. Vandenabeele,et al.  The Activation of the c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase Signaling Pathways Protects HeLa Cells from Apoptosis Following Photodynamic Therapy with Hypericin* , 1999, The Journal of Biological Chemistry.

[6]  Y. Izumi,et al.  Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling. , 1999, Journal of molecular and cellular cardiology.

[7]  Shokei Kim,et al.  Activation of mitogen-activated protein kinases in cardiovascular hypertrophy and remodeling. , 1999, Japanese journal of pharmacology.

[8]  R M Peshock,et al.  Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. , 1998, Journal of the American College of Cardiology.

[9]  ShinyaYamanaka,et al.  Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension , 1998 .

[10]  Shokei Kim,et al.  Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension. , 1998, Circulation research.

[11]  Y. Ro,et al.  Microvascular integrity as a predictor of left ventricular remodeling after acute anterior wall myocardial infarction. , 1998, Journal of Korean medical science.

[12]  A. Harken,et al.  Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism. , 1998, Surgery.

[13]  A. Clerk,et al.  Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart. , 1998, The Biochemical journal.

[14]  Shokei Kim,et al.  Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. , 1998, Circulation.

[15]  H. Iwao,et al.  Assessment of cardiac function and gene expression at an early phase after myocardial infarction. , 1998, Japanese heart journal.

[16]  A. Roulston,et al.  Early Activation of c-Jun N-terminal Kinase and p38 Kinase Regulate Cell Survival in Response to Tumor Necrosis Factor α* , 1998, The Journal of Biological Chemistry.

[17]  H. Matsubara,et al.  Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. , 1998, Circulation research.

[18]  D. Zechner,et al.  MKK6 Activates Myocardial Cell NF-κB and Inhibits Apoptosis in a p38 Mitogen-activated Protein Kinase-dependent Manner* , 1998, The Journal of Biological Chemistry.

[19]  Shokei Kim,et al.  Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. , 1998, Cardiovascular research.

[20]  N. El-Sherif,et al.  Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction. , 1998, Journal of molecular and cellular cardiology.

[21]  Shokei Kim,et al.  Cardiac mitogen-activated protein kinase activities are chronically increased in stroke-prone hypertensive rats. , 1998, Hypertension.

[22]  Y. Yazaki,et al.  Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. , 1997, Biochemical and biophysical research communications.

[23]  C. Glembotski,et al.  Collaborative Roles for c-Jun N-terminal Kinase, c-Jun, Serum Response Factor, and Sp1 in Calcium-regulated Myocardial Gene Expression* , 1997, The Journal of Biological Chemistry.

[24]  Shokei Kim,et al.  Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activities are continuously and differentially increased in aorta of hypertensive rats. , 1997, Biochemical and biophysical research communications.

[25]  K. Chien,et al.  The MEKK-JNK Pathway Is Stimulated by α1-Adrenergic Receptor and Ras Activation and Is Associated with in Vitroand in Vivo Cardiac Hypertrophy* , 1997, The Journal of Biological Chemistry.

[26]  Y. Zou,et al.  Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. , 1997, Circulation research.

[27]  A. Ashworth,et al.  Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. , 1996, Circulation research.

[28]  Y. Yazaki,et al.  Mechanical stretch activates the stress‐activated protein kinase in cardiac myocytes , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Y. Yazaki,et al.  Hypoxia and hypoxia/reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases, and S6 kinase in cultured rat cardiac myocytes. , 1996, Circulation research.

[30]  P. Sugden,et al.  Cellular Stresses Differentially Activate c-Jun N-terminal Protein Kinases and Extracellular Signal-regulated Protein Kinases in Cultured Ventricular Myocytes (*) , 1995, The Journal of Biological Chemistry.

[31]  R. Kloner,et al.  Reperfusion injury induces apoptosis in rabbit cardiomyocytes. , 1994, The Journal of clinical investigation.

[32]  M. Karin,et al.  c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases , 1994, Molecular and cellular biology.

[33]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.

[34]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[35]  A. Rumley,et al.  Neuroendocrine activation after acute myocardial infarction. , 1988, British heart journal.

[36]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[37]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[38]  H. Dargie,et al.  Neuroendocrine Activation in Acute Myocardial Infarction , 1987, Journal of cardiovascular pharmacology.

[39]  W Grossman,et al.  Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. , 1986, Circulation.

[40]  P. Anversa,et al.  Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy. , 1985, The American journal of physiology.

[41]  B. Bulkley,et al.  Global cardiac remodeling after acute myocardial infarction: a study in the rat model. , 1985, Journal of the American College of Cardiology.

[42]  M. Fishbein,et al.  Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. , 1978, The American journal of pathology.